Amarin Plcuk (AMRN) Directors and Executive Officers - CSIMarket
CSIMarket
 
Amarin Corp Plcuk  (NASDAQ: AMRN)

Amarin Corp Plcuk

Officers & Directors


Tom Reilly
Executive Vice President and Chief Financial Officer - (Principal Financial and Accounting Officer)

Louis Sterling III
Director

Paul Cohen, M.D.
Director

Odysseas Kostas, M.D.
Director

Patrick Holt
Director, President and Chief Executive Officer - (Principal Executive Officer)

Keith L. Horn
Director

Diane E. Sullivan
Director

Patrice Bonfiglio
Director

Mark DiPaolo
Director ,

Amarin Corp Plcuk currently has 1650 employees.

  News about Amarin Corp Plcuk Key Personnel

The Urgent Need for Regulatory Action to Safeguard Patients from the Ineffective Cardiovascular Drug, Fenofibrate



In recent months, Amarin Corporation has been at the forefront of advocating for patient safety and pushing for regulatory action against the prescribing of fenofibrate in patients at risk of cardiovascular events. Supported by the HealthyWomen s Citizen Petition, Amarin brings attention to the risks associated with this drug, which has been proven to provide no benefit in improving cardiovascular outcomes. This article explores Amarin s concerns, sheds light on the valuable contributions made by HealthyWomen s Citizen Petition, and emphasizes the pressing need for the FDA to take immediate action to safeguard patients from the potential harm of fenofibrate.
The Ineffectiveness of Fenofibrate:<...






AMRN Management Effectiveness AMRN Revenue per Employee AMRN Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.